🚀 Trump pushes for rate cuts

In partnership with

Prepare for your next business move with our International Hiring Guide

At Deel, we've simplified a world's worth of global hiring information. Our expert teams can help you navigate quick and compliant hiring in 150+ countries and so much more.

Download our guide

Market Overview
Read time 1.4 minutes

Year To Date Performances:

1. Donald Trump ramped up his pressure on Fed Chair Jerome Powell Thursday, slamming him on Truth Social as “Too Late Jerome” and saying “Powell’s termination cannot come fast enough.” The post followed Powell’s speech in Chicago, where the Fed chief acknowledged the economic tightrope created by Trump’s new tariffs. While the White House downplayed Trump’s remarks as venting rather than a real firing threat, this marked Trump’s most explicit call yet for Powell’s removal—despite the fact that, legally, he can’t do it. Powell’s term runs through May 2026.

2. A U.S. federal judge ruled Thursday that Google illegally monopolized key parts of the online advertising tech market, specifically dominating publisher ad servers and ad exchanges. While the DOJ failed to prove a monopoly in advertiser ad networks, this decision marks a major victory for antitrust enforcers and could pave the way for a forced breakup—potentially requiring Google to sell off its Ad Manager suite. It’s the latest legal front Google faces, with another trial next week that could target Chrome and its search dominance. The ruling underscores mounting global pressure to rein in Big Tech’s grip on digital markets.

3. Eli Lilly’s stock surged 14% Thursday after its daily weight-loss pill, orforglipron, succeeded in its first late-stage trial on Type 2 diabetes patients. The pill helped lower blood sugar and led to an average 7.9% weight loss over 40 weeks, positioning it as a promising oral alternative to blockbuster injectables like Ozempic and Wegovy. While it missed some expectations for blood sugar reduction, analysts see strong commercial potential given its ease of use, manufacturing scalability, and three-year head start over rivals. Eli Lilly aims to seek obesity approval by year’s end.

4. Headlines

   1. Hermes has announced that it will increase the prices of all products in the US to account for Trump’s tariffs.

   2. The European Central Bank has cut rates due to the declining economic outlook since the implementation of Trump’s tariffs.

   _{* This is sponsored content.}

Are you looking to grow your business? Here is how I can help: 

📱Book a Strategy Call to get 1:1 feedback on your pitch, pitch deck and/or fundraising strategy. (If you need general startup advice, then reply to this email, and I’ll let you know if/how I can help.)

Take From the Rich, Give to the People, Big Data’s Robinhood

Big tech uses our data to pad their pockets. Facebook alone makes $42B a year. But modern-day Robinhood, $MODE, allows everyone to share in the profits. 45M+ users and $60M+ in revenue later, Mode prepares for an IPO.

Invest before 5/1 price change.

_{*An intent to IPO is no guarantee that an actual IPO will occur. Please read the offering circular and related risks at invest.modemobile.com.
*The Deloitte rankings are based on submitted applications and public company database research.}

Onwards and Upwards,

Liam Gill